VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations

by | Jun 5, 2026 | Clinical Trials | 0 comments

​ Conditions: Brain Cancer

Interventions: Drug: Vorasidenib; Drug: Lomustine

Sponsors: Megan Mantica; Institut de Recherches Internationales Servier

Not yet recruiting Conditions: Brain Cancer
Interventions: Drug: Vorasidenib; Drug: Lomustine
Sponsors: Megan Mantica; Institut de Recherches Internationales Servier
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *